Reduced activity of monoamine oxidase in the rat brain following repeated nandrolone decanoate administration

Brain Research

Volumn 1219, Issue , 2008, Pages 103-110

  Birgner, Carolina ^a   Kindlundh Högberg, Anna M S ^a   Oreland, Lars ^a   Alsiö, Johan ^a   Lindblom, Jonas ^a   Schiöth, Helgi B ^a   Bergström, Lena ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Anabolic androgenic steroid; Monoamine oxidase; Nandrolone decanoate

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; ANDROGEN; CATECHOL METHYLTRANSFERASE; NANDROLONE DECANOATE;

AGGRESSION; AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG EFFECT; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; MALE; NONHUMAN; PRIORITY JOURNAL; PUTAMEN; RADIOMETRY; RAT; REAL TIME POLYMERASE CHAIN REACTION; SUBSTANTIA NIGRA;

ANABOLIC AGENTS; ANALYSIS OF VARIANCE; ANIMALS; BRAIN; DRUG ADMINISTRATION SCHEDULE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MALE; MONOAMINE OXIDASE; NANDROLONE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

RATTUS;

EID: 45849103093     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.05.014     Document Type: Article

References (55)

1. Bahrke M.S., Wright J.E., Strauss R.H., and Catlin D.H. Psychological moods and subjectively perceived behavioral and somatic changes accompanying anabolic-androgenic steroid use. Am. J. Sports Med. 20 (1992) 717-724
2. Ballard C.L., and Wood R.I. Intracerebroventricular self-administration of commonly abused anabolic-androgenic steroids in male hamsters (Mesocricetus auratus): nandrolone, drostanolone, oxymetholone, and stanozolol. Behav. Neurosci. 119 (2005) 752-758
3. Birgner C., Kindlundh-Hogberg A.M.S., Ploj K., Lindblom J., Nyberg F., and Bergstrom L. Effects on rat brain dopamine and DOPAC levels after sub-chronic nandrolone administration followed by an amphetamine challenge. Pharmacologyonline 3 (2006) 99-108
4. Birgner C., Kindlundh-Hogberg A.M., Nyberg F., and Bergstrom L. Altered extracellular levels of DOPAC and HVA in the rat nucleus accumbens shell in response to sub-chronic nandrolone administration and a subsequent amphetamine challenge. Neurosci. Lett. 412 (2007) 168-172
5. Calabrese E.J. Androgens: biphasic dose responses. Crit. Rev. Toxicol. 31 (2001) 517-522
6. Calabrese E.J. Estrogen and related compounds: biphasic dose responses. Crit. Rev. Toxicol. 31 (2001) 503-515
7. Cases O., Seif I., Grimsby J., Gaspar P., Chen K., Pournin S., Muller U., Aguet M., Babinet C., Shih J.C., et al. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science 268 (1995) 1763-1766
8. Corrigan B. Anabolic steroids and the mind. Med. J. Aust. 165 (1996) 222-226
9. Everitt B.J., and Robbins T.W. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat. Neurosci. 8 (2005) 1481-1489
10. Fowler C.J., von Knorring L., and Oreland L. Platelet monoamine oxidase activity in sensation seekers. Psychiatry Res. 3 (1980) 273-279
11. Fudala P.J., Weinrieb R.M., Calarco J.S., Kampman K.M., and Boardman C. An evaluation of anabolic-androgenic steroid abusers over a period of 1 year: seven case studies. Ann. Clin. Psychiatry 15 (2003) 121-130
12. Gregg T.R., and Siegel A. Brain structures and neurotransmitters regulating aggression in cats: implications for human aggression. Prog. Neuro-psychopharmacol. Biol. Psychiatry 25 (2001) 91-140
13. Grimes J.M., and Melloni Jr. R.H. Serotonin modulates offensive attack in adolescent anabolic steroid-treated hamsters. Pharmacol. Biochem. Behav. 73 (2002) 713-721
14. Grimes J.M., Ricci L.A., and Melloni Jr. R.H. Alterations in anterior hypothalamic vasopressin, but not serotonin, correlate with the temporal onset of aggressive behavior during adolescent anabolic-androgenic steroid exposure in hamsters (Mesocricetus auratus). Behav. Neurosci. 121 (2007) 941-948
15. Gundlah C., Lu N.Z., and Bethea C.L. Ovarian steroid regulation of monoamine oxidase-A and -B mRNAs in the macaque dorsal raphe and hypothalamic nuclei. Psychopharmacology (Berl) 160 (2002) 271-282
16. Hallman J., Oreland L., Edman G., and Schalling D. Thrombocyte monoamine oxidase activity and personality traits in women with severe premenstrual syndrome. Acta Psychiatr. Scand. 76 (1987) 225-234
17. Johansson P., Lindqvist A., Nyberg F., and Fahlke C. Anabolic androgenic steroids affects alcohol intake, defensive behaviors and brain opioid peptides in the rat. Pharmacol. Biochem. Behav. 67 (2000) 271-279
18. Kanayama G., Cohane G.H., Weiss R.D., and Pope H.G. Past anabolic-androgenic steroid use among men admitted for substance abuse treatment: an underrecognized problem?. J. Clin. Psychiatry 64 (2003) 156-160
19. Keleta Y.B., Lumia A.R., Anderson G.M., and McGinnis M.Y. Behavioral effects of pubertal anabolic androgenic steroid exposure in male rats with low serotonin. Brain Res. 1132 (2007) 129-138
20. Kindlundh A.M., Isacson D.G., Berglund L., and Nyberg F. Factors associated with adolescent use of doping agents: anabolic-androgenic steroids. Addiction 94 (1999) 543-553
21. Kindlundh A.M., Lindblom J., Bergstrom L., Wikberg J.E., and Nyberg F. The anabolic-androgenic steroid nandrolone decanoate affects the density of dopamine receptors in the male rat brain. Eur. J. Neurosci. 13 (2001) 291-296
22. Kindlundh A.M., Bergstrom M., Monazzam A., Hallberg M., Blomqvist G., Langstrom B., and Nyberg F. Dopaminergic effects after chronic treatment with nandrolone visualized in rat brain by positron emission tomography. Prog. Neuro-psychopharmacol. Biol. Psychiatry 26 (2002) 1303-1308
23. Kindlundh A.M., Lindblom J., and Nyberg F. Chronic administration with nandrolone decanoate induces alterations in the gene-transcript content of dopamine D(1)- and D(2)-receptors in the rat brain. Brain Res. 979 (2003) 37-42
24. Kindlundh A.M., Rahman S., Lindblom J., and Nyberg F. Increased dopamine transporter density in the male rat brain following chronic nandrolone decanoate administration. Neurosci. Lett. 356 (2004) 131-134
25. Kreek M.J., Nielsen D.A., Butelman E.R., and LaForge K.S. Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nat. Neurosci. 8 (2005) 1450-1457
26. Kurling S., Kankaanpaa A., Ellermaa S., Karila T., and Seppala T. The effect of sub-chronic nandrolone decanoate treatment on dopaminergic and serotonergic neuronal systems in the brains of rats. Brain Res. 1044 (2005) 67-75
27. Kurling S., Kankaanpaa A., and Seppala T. Sub-chronic nandrolone treatment modifies neurochemical and behavioral effects of amphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in rats. Brain Res. 189 (2008) 191-201
28. Lindblom J., Johansson A., Holmgren A., Grandin E., Nedergard C., Fredriksson R., and Schioth H.B. Increased mRNA levels of tyrosine hydroxylase and dopamine transporter in the VTA of male rats after chronic food restriction. Eur. J. Neurosci. 23 (2006) 180-186
29. Lindqvist A.S., Johansson-Steensland P., Nyberg F., and Fahlke C. Anabolic androgenic steroid affects competitive behaviour, behavioural response to ethanol and brain serotonin levels. Behav. Brain Res. 133 (2002) 21-29
30. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(- Delta Delta C(T)) Method. Methods 25 (2001) 402-408
31. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
32. McGinnis M.Y., Lumia A.R., Breuer M.E., and Possidente B. Physical provocation potentiates aggression in male rats receiving anabolic androgenic steroids. Horm. Behav. 41 (2002) 101-110
33. Melloni Jr. R.H., Connor D.F., Hang P.T., Harrison R.J., and Ferris C.F. Anabolic-androgenic steroid exposure during adolescence and aggressive behavior in golden hamsters. Physiol. Behav. 61 (1997) 359-364
34. Oreland L. Platelet monoamine oxidase, personality and alcoholism: the rise, fall and resurrection. Neurotoxicology 25 (2004) 79-89
35. Oreland L., Arai Y., and Stenstrom A. The effect of deprenyl (selegiline) on intra- and extraneuronal dopamine oxidation. Acta Neurol. Scand., Suppl. 95 (1983) 81-85
36. Oreland L., Nilsson K., Damberg M., and Hallman J. Monoamine oxidases: activities, genotypes and the shaping of behaviour. J. Neural Transm. 114 (2007) 817-822
37. Ou X.M., Chen K., and Shih J.C. Glucocorticoid and androgen activation of monoamine oxidase A is regulated differently by R1 and Sp1. J. Biol. Chem. 281 (2006) 21512-21525
38. Petersson A., Garle M., Holmgren P., Druid H., Krantz P., and Thiblin I. Toxicological findings and manner of death in autopsied users of anabolic androgenic steroids. Drug Alcohol Depend. 81 (2006) 241-249
39. Pinna G., Costa E., and Guidotti A. Changes in brain testosterone and allopregnanolone biosynthesis elicit aggressive behavior. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 2135-2140
40. Pivac N., Knezevic J., Mustapic M., Dezeljin M., Muck-Seler D., Kozaric-Kovacic D., Balija M., Matijevic T., and Pavelic J. The lack of association between monoamine oxidase (MAO) intron 13 polymorphism and platelet MAO-B activity among men. Life Sci. 79 (2006) 45-49
41. Pope Jr. H.G., and Katz D.L. Psychiatric and medical effects of anabolic-androgenic steroid use. A controlled study of 160 athletes. Arch. Gen. Psychiatry 51 (1994) 375-382
42. Ramakers C., Ruijter J.M., Deprez R.H., and Moorman A.F. Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci. Lett. 339 (2003) 62-66
43. Ricci L.A., Rasakham K., Grimes J.M., and Melloni Jr. R.H. Serotonin-1A receptor activity and expression modulate adolescent anabolic/androgenic steroid-induced aggression in hamsters. Pharmacol. Biochem. Behav. 85 (2006) 1-11
44. Schroeder J.P., and Packard M.G. Role of dopamine receptor subtypes in the acquisition of a testosterone conditioned place preference in rats. Neurosci. Lett. 282 (2000) 17-20
45. Sjoberg R.L., Ducci F., Barr C.S., Newman T.K., Dell'osso L., Virkkunen M., and Goldman D. A non-additive interaction of a functional MAO-A VNTR and testosterone predicts antisocial behavior. Neuropsychopharmacology 33 (2008) 425-430
46. Skondras M., Markianos M., Botsis A., Bistolaki E., and Christodoulou G. Platelet monoamine oxidase activity and psychometric correlates in male violent offenders imprisoned for homicide or other violent acts. Eur. Arch. Psychiatry Clin. Neurosci. 254 (2004) 380-386
47. Smith L.J., Henderson J.A., Abell C.W., and Bethea C.L. Effects of ovarian steroids and raloxifene on proteins that synthesize, transport, and degrade serotonin in the raphe region of macaques. Neuropsychopharmacology 29 (2004) 2035-2045
48. Thiblin I., and Parlklo T. Anabolic androgenic steroids and violence. Acta Psychiatr. Scand., Suppl. (2002) 125-128
49. Thiblin I., Finn A., Ross S.B., and Stenfors C. Increased dopaminergic and 5-hydroxytryptaminergic activities in male rat brain following long-term treatment with anabolic androgenic steroids. Br. J. Pharmacol. 126 (1999) 1301-1306
50. van der Vies J. Implications of basic pharmacology in the therapy with esters of nandrolone. Acta Endocrinol. Suppl. (Copenh) 271 (1985) 38-44
51. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., and Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3 (2002) RESEARCH0034
52. Vergnes M., Depaulis A., Boehrer A., and Kempf E. Selective increase of offensive behavior in the rat following intrahypothalamic 5,7-DHT-induced serotonin depletion. Behav. Brain Res. 29 (1988) 85-91
53. von Knorring A.L., Hallman J., von Knorring L., and Oreland L. Platelet monoamine oxidase activity in type 1 and type 2 alcoholism. Alcohol Alcohol. 26 (1991) 409-416
54. Waldmeier P.C. Amine oxidases and their endogenous substrates (with special reference to monoamine oxidase and the brain). J. Neural. Transm., Suppl. 23 (1987) 55-72
55. Yesalis C.E., and Bahrke M.S. Anabolic-androgenic steroids. Current issues. Sports Med. 19 (1995) 326-340